Novozymes AS Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 16 trades in Novozymes AS (PINK: NVZMY) since 2017, across 5 members, worth an estimated $912.01K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 8 buys against 8 sells, an evenly split skew, with Democratic members responsible for 38% of the trades and Republican members 62%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Novozymes AS (NVZMY) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Novozymes AS congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Josh Gottheimer House | Jul 7, 2026 | Jun 1, 2026 | 36 days | SELL |  $1,001 - $15,000 | +20.39% | Joint |
Novozymes AS (NVZMY) congressional trading FAQ
Can members of Congress legally trade Novozymes AS (NVZMY) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Novozymes AS (NVZMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Novozymes AS (NVZMY) trades public?
Yes. Every congressional trade in Novozymes AS (NVZMY) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Novozymes AS (NVZMY)?
Members of Congress have disclosed 16 trades in Novozymes AS (NVZMY) worth $912.01K across 5 members, according to public STOCK Act filings.
Which members of Congress have traded Novozymes AS (NVZMY)?
Recent and active filers of Novozymes AS (NVZMY) disclosures include Josh Gottheimer. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Novozymes AS (NVZMY) more?
Across disclosed Novozymes AS (NVZMY) trades, 38% were by Democrats and 63% by Republicans, led by Republicans (63%).
What is the most recent congressional Novozymes AS (NVZMY) trade?
The most recent disclosed Novozymes AS (NVZMY) trade was a sale by Josh Gottheimer, filed Jul 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewNovozymes AS (NVZMY) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.